Clinical Trials
39 trialsA Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
STRATEGIC-1
GERCOR - Multidisciplinary Oncology Cooperative Group
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer
Tang-Du Hospital
CRC - PTX
Tanta University
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
SIRTCI
Federation Francophone de Cancerologie Digestive
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Tang-Du Hospital
NECI
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
PRECISE CURATE.AI Pilot Clinical Trial
National University Hospital, Singapore
NICE
Nanfang Hospital, Southern Medical University
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Third Affiliated Hospital, Sun Yat-Sen University
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Fudan University
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Fudan University
ARMANI
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
China Medical University, China
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
Fudan University
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Fudan University
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Anhui Provincial Hospital
XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
Sun Yat-sen University
XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma
Tianjin Medical University Cancer Institute and Hospital
EHTLAGCRGD2
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
PREPARE
National Cancer Center, Korea
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
Peking Union Medical College Hospital
PEPCORLI
The First Affiliated Hospital with Nanjing Medical University
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
Fudan University
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy
Jiangsu Province Hospital of Traditional Chinese Medicine
A Phase â…¡ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
Fudan University
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
Nanjing NingQi Medicine Science and Technology Co., Ltd.
ANGIOSWITCH
Grupo Hospital de Madrid
Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer
Harbin Medical University
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
Guangdong Provincial People's Hospital